Paroxetine for the prevention of depression induced by high-dose interferon alfa.
about
Cytokines sing the blues: inflammation and the pathogenesis of depressionInflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivityAntiviral drugs for viruses other than human immunodeficiency virusInflammation in depression: is adiposity a cause?KASL clinical practice guidelines: management of hepatitis CStress-Related Immune Markers in Depression: Implications for TreatmentInnate and adaptive immunity in the development of depression: An update on current knowledge and technological advancesA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesNeuropsychiatric comorbidity in obesity: role of inflammatory processesAntidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysisCytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaiseToxicities of Immunotherapy for the PractitionerDepression during pegylated interferon-alpha plus ribavirin therapy: prevalence and predictionPsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorNeuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stressSelective serotonin re-uptake inhibitors and the risk of bleedingAlcoholism and inflammation: neuroimmunology of behavioral and mood disordersPredictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialInflammation and its discontents: the role of cytokines in the pathophysiology of major depressionDepressive symptoms are associated with worsened severity of the metabolic syndrome in African American women independent of lifestyle factors: A consideration of mechanistic links from the Jackson heart studyEnhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats.Peripheral inflammation is associated with remote global gene expression changes in the brain.Brain Structures Implicated in Inflammation-Associated Depression.Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression.The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factorNew agreement measures based on survival processes.Animal models to improve our understanding and treatment of suicidal behaviorAssessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.Depression in cancer patients.Early attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes.Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatmentThe changing microbial environment and chronic inflammatory disorders.The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.Depression subtypes in pediatric inflammatory bowel disease.Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test.Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis.
P2860
Q24633065-DB55202F-E62C-4241-9F85-B3E3707AD88AQ24634258-44E94839-302F-4811-894B-38B94E155B25Q24635330-77336906-802E-466F-96A3-9AB3A8244F76Q24635451-E3F9A933-4558-484E-AD5F-79160AEF62ACQ26752471-D65A6511-B258-44D7-88EA-C834EA9C2269Q26771607-CB6753FF-3103-4A3A-9353-13D97E1084DAQ26775316-0B95CC91-81FB-41F1-A5CF-9B76F13A9721Q26786354-E51A3B42-4968-4ED9-87B9-1D4809B7FD00Q26829880-3C91B337-9AC9-4064-AA53-FE0FFF8998E9Q26864986-A666BC9F-5B2C-40E2-B5C3-E64BDC4244ABQ27001628-ED769FE8-D5A7-43C5-9797-62A4A54E1961Q27008140-21DD4626-6389-44E3-A71D-3ABC32E4B342Q27477533-D8AC5A07-5B51-4D7D-8490-69612F903C2CQ27694728-94F73AB6-152C-49DE-B8A5-1901A70209E5Q28069771-35FBDDD3-69CE-470B-9271-8BFB5CD7A236Q28211440-23DBF200-E7EC-4639-8E16-A60E94584C5FQ28302013-8622D582-57C3-4166-9513-F941961DBBEBQ28710054-8742D56F-4469-4DDC-AD17-911F23179A8DQ29617326-97A52E31-F20D-41BD-83FC-E89726910271Q30277172-719781F4-DF36-4B1A-AE16-3FEDE6358399Q30538444-72CC96EA-0F3F-4C55-9F10-46BD3269FE70Q30578175-2251EEA8-6DB0-4EE5-A111-12CF3F5C66EAQ31106139-0B73CADB-15C5-45F9-A134-FA283AF125B1Q31158272-1B43EC18-8D99-412E-8C3E-B35CCCCC648FQ33351796-2FED6D75-1359-4E5E-8CA4-5560CAAC1DAEQ33353554-B0CD48B3-2368-4F0E-B835-97E8E708AFA4Q33411619-7A6A6F4C-8794-42D6-8782-807CFF895812Q33598400-DC8DE9F5-3209-475F-B904-4A8B1800E1A8Q33598504-39A97C0A-A0F0-4246-82DB-98B10E7F5926Q33635653-34D2DFFC-35AD-4431-851F-C4A4D5861986Q33656211-B57DDAC4-7739-48C3-91A5-FC857FCB9C23Q33697929-BFDC997D-396C-4BDC-A0E3-DD7D4C35C6F2Q33767298-58F530B9-78B3-41CA-88C7-A6D71D990B46Q33816643-50B2D52E-B2A6-4309-9C50-10FCB146372AQ33846659-507C36BA-B5F2-41A7-ADC0-2521EE3857BFQ33863747-FC8BECDE-4D13-407B-9855-B6FA2742AE53Q33963625-863E6630-F1A5-438B-8E69-9E747C33AC1AQ34001639-45AE0467-E509-45A4-8A0A-51CC6BF34A66Q34023769-5BC42168-EF94-4B2F-95F9-75A0EAE4AB5DQ34053569-80D5D2B3-1509-4694-95BE-D7C3FCE520F3
P2860
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@en
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@nl
type
label
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@en
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@nl
prefLabel
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@en
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@nl
P2093
P1476
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
@en
P2093
A H Miller
A K Manatunga
C B Nemeroff
D H Lawson
D L Musselman
J F Gumnick
R S Goodkin
P304
P356
10.1056/NEJM200103293441303
P407
P577
2001-03-01T00:00:00Z